Financhill
Back

Exelixis Quote, Financials, Valuation and Earnings

Exelixis Price Quote

$33.29

Exelixis Key Stats

Buy
72
Exelixis (EXEL) is a Buy

Day range:
$33.11 - $33.68
52-week range:
$19.20 - $36.97
Dividend yield:
0%
P/E ratio:
51.22
P/S ratio:
4.81
P/B ratio:
4.18%

Volume:
6.8M
Avg. volume:
2.1M
1-year change:
43.37%
Market cap:
$9.5B
Revenue:
$1.8B
EPS:
$1.56

How Much Does Exelixis Make?

Data Unavailable

Is Exelixis Growing As A Company?

Data Unavailable

Exelixis Stock Price Performance

  • Did Exelixis Stock Go Up Last Month?
    Exelixis share price went down by -3.93% last month
  • Did EXEL's Share Price Rise Over The Last Year?
    EXEL share price rose by 43.37% over the past 1 year

What Is Exelixis 52-Week High & Low?

  • What Is Exelixis’s 52-Week High Share Price?
    Exelixis has traded as high as $36.97 over the past 52 weeks
  • What Is Exelixis’s 52-Week Low Share Price?
    Exelixis has traded as low as $19.20 over the past 52 weeks

Exelixis Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Exelixis?

Data Unavailable

Is Exelixis Cash Flow Positive?

Data Unavailable

Exelixis Return On Invested Capital

Data Unavailable

Exelixis Earnings Date & Stock Price

  • What Is Exelixis's Stock Price Today?
    A single share of EXEL can be purchased today for 33.29
  • What Is Exelixis’s Stock Symbol?
    Exelixis trades on the nasdaq under the ticker symbol: EXEL
  • When Is Exelixis’s Next Earnings Date?
    The next quarterly earnings date for Exelixis is scheduled on February 6, 2025
  • When Is EXEL's next ex-dividend date?
    Exelixis's next ex-dividend date is December 22, 2024
  • How To Buy Exelixis Stock?
    You can buy Exelixis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Exelixis Competitors

  • Who Are Exelixis's Competitors?
    Below is a list of companies who compete with Exelixis or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)
    • Sarepta Therapeutics Inc (SRPT)

Exelixis Dividend Yield

Data Unavailable

Exelixis Analyst Estimates

YoY Growth Past Surprise
EPS: 12166.18% 12.02%
Revenue: 14.33% 10.04%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 33.06
Downside from Last Price: -0.68%

Major Shareholders

Data Unavailable